ExodusPoint Capital Management, LP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 3 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$1,655
-10.6%
710,355
-8.7%
0.02%
+6.7%
Q2 2023$1,851
+143.2%
777,760
+88.0%
0.02%
+150.0%
Q1 2023$761
+17.3%
413,764
+21.1%
0.01%
-33.3%
Q4 2022$649
-99.9%
341,720
+67.3%
0.01%
+50.0%
Q3 2022$437,000
+3.6%
204,316
+37.1%
0.01%
+20.0%
Q2 2022$422,000149,0350.01%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders